Cheshire, UK--(Marketwire - July 22, 2008) - London, UK; Brentwood, TN, US; 22 July 2008 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, today provides its Interim Management Statement for the period 31 March to 21 July 2008. This statement summarises comments to be made today by Stuart Wallis, Chairman of Protherics’ at the Annual General Meeting at midday today.
